Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intestinal radioprotection by two new agents applied topically.

J P Delaney1, M Bonsack, P Hall

  • 1Department of Surgery, University of Minnesota, Minneapolis 55455.

Annals of Surgery
|October 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MEK inhibition induces expression of differentiation marker Keratin 10 in human keratinocytes.

Pathology, research and practice·2023
Same author

Breast cancer screening: time to target women at risk.

British journal of cancer·2013
Same author

Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial.

Clinical oncology (Royal College of Radiologists (Great Britain))·2012
Same author

Risk of treatment-related esophageal cancer among breast cancer survivors.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Diagnostic value of the rapid assessment of postural instability in Parkinson's disease (RAPID) questionnaire.

International journal of clinical practice·2012
Same author

Mammographic density and molecular subtypes of breast cancer.

British journal of cancer·2012

Two novel antioxidant drugs, U-74500A and U-78518F, demonstrated effectiveness in protecting the intestine from radiation damage. These topical agents reduced crypt loss, indicating potential for radioprotection in the gastrointestinal tract.

Area of Science:

  • Pharmacology
  • Radiation Biology
  • Gastroenterology

Background:

  • Radiation therapy for abdominal cancers can cause significant intestinal injury.
  • Developing effective radioprotectants for the gastrointestinal tract is crucial for improving patient outcomes.
  • Antioxidants that inhibit peroxidation and scavenge free radicals are potential candidates for radioprotection.

Purpose of the Study:

  • To evaluate two novel antioxidant drugs as topical radioprotectants for the rat intestine.
  • To assess the efficacy of a 21-amino steroid (U-74500A) and a vitamin E-like compound (U-78518F) in mitigating radiation-induced intestinal damage.

Main Methods:

  • A loop of rat mid-intestine was exteriorized and irradiated.
  • Intestinal segments were filled with either the antioxidant drugs or a vehicle control.

Related Experiment Videos

  • Crypt numbers and mucosal height were measured 5 days post-irradiation to assess injury.

    • Main Results:

    • The 21-amino steroid (U-74500A) reduced crypt loss by approximately 40%.
    • The vitamin E-like compound (U-78518F) reduced crypt loss by approximately 60%.
    • Both drugs provided significant protection compared to vehicle-treated controls.

    Conclusions:

    • Luminal antioxidant drugs can offer partial protection against acute radiation damage to the intestinal mucosa.
    • The tested antioxidant agents (U-74500A and U-78518F) are effective and potentially useful for intestinal radioprotection.